10.06.06
IBT Laboratories has named Michelle Hunter, Ph.D., M.B.A. vice president of sales, marketing and corporate development. Dr. Hunter, an experienced clinical research scientist and pharmaceutical executive, is responsible for guiding the company’s business development and marketing initiatives. She is also responsible for heading up the expansion of the company's clinical trial testing services that target the pharmaceutical, biopharmaceutical and contract research markets.
“Dr. Hunter brings to IBT a unique blend of clinical research and executive leadership experience in the global pharmaceutical industry,” said John F. Halsey, Ph.D., the company’s president and chief executive officer. “IBT will leverage her vast expertise across these disciplines to meet the explosive market demand for contract immunology research and testing. Dr. Hunter’s broad perspective and knowledge of the industry will enable us to develop and deliver new solutions that further help our clients streamline their R&D processes, reduce development costs and bring drugs to market faster.”
Dr. Hunter’s pharmaceutical experience includes seven years in strategic account sales and executive sales management at PRA International. Most recently, she held the position of vice president of global business development and marketing at Focus Bio-Inova, a specialty microbiology and central laboratory serving the international pharmaceutical market. In a clinical capacity, Dr. Hunter was integral in the global clinical development of two neuroscience compounds at Bristol-Myers Squibb. She has also held research scientist positions at the University of Connecticut and held an adjunct faculty position in the university’s psychology department for eight years.
“Dr. Hunter brings to IBT a unique blend of clinical research and executive leadership experience in the global pharmaceutical industry,” said John F. Halsey, Ph.D., the company’s president and chief executive officer. “IBT will leverage her vast expertise across these disciplines to meet the explosive market demand for contract immunology research and testing. Dr. Hunter’s broad perspective and knowledge of the industry will enable us to develop and deliver new solutions that further help our clients streamline their R&D processes, reduce development costs and bring drugs to market faster.”
Dr. Hunter’s pharmaceutical experience includes seven years in strategic account sales and executive sales management at PRA International. Most recently, she held the position of vice president of global business development and marketing at Focus Bio-Inova, a specialty microbiology and central laboratory serving the international pharmaceutical market. In a clinical capacity, Dr. Hunter was integral in the global clinical development of two neuroscience compounds at Bristol-Myers Squibb. She has also held research scientist positions at the University of Connecticut and held an adjunct faculty position in the university’s psychology department for eight years.